-
HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody
2026-09-21
A scenario-based laboratory guide to using HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody, SKU K1206, for reproducible fluorescence detection in viability, proliferation, cytotoxicity, and immunostaining workflows. It explains compatibility, controls, storage, optimization, and vendor-selection considerations without overstating product performance beyond the available dossier.
-
ABT-888 (Veliparib) Experimental Workflows
2026-09-21
ABT-888 (Veliparib) enables controlled DNA repair inhibition for chemotherapy and radiation sensitization studies, with especially useful applications in colorectal cancer and microsatellite instability models. This practical guide covers assay design, combination testing, model selection, troubleshooting, and how recent replication-stress research can refine experimental choices.
-
Arachidonic Acid in Ischemia–Reperfusion Assays
2026-09-20
Arachidonic Acid is more than an inflammatory stimulus: it is a time-sensitive probe of membrane remodeling, eicosanoid biosynthesis, and barrier injury. This guide connects lipid-signaling assay design with recent selective cerebral perfusion research while defining practical controls, limitations, and translational opportunities.
-
Annexin V-PE Apoptosis Detection Kit Workflow
2026-09-19
Build a rapid, fixation-free apoptosis workflow for live lymphoma cells, cytotoxicity studies, and pathway-focused experiments. This guide shows how Annexin V-PE staining complements flow cytometry, microscopy, and molecular readouts without confusing phosphatidylserine exposure with definitive apoptotic mechanism.
-
IKK–β-TrCP2 Control of TFEB Stability
2026-09-19
The reference study identifies an IKK-driven phosphorylation-ubiquitination cascade that controls TFEB turnover through a previously unrecognized phospho-degron and adjacent lysine residues targeted by β-TrCP2. Its integrated use of kinome screening, phosphorylation assays, mass spectrometry, mutagenesis, and cellular functional tests provides a mechanistic framework for protein phosphorylation signaling and TFEB-dependent clearance pathways.
-
SCH772984: ERK1/2 Inhibitor Workflows
2026-09-18
SCH772984 enables selective interrogation of ERK1/2 signaling in oncogenic MAPK models, from rapid phosphoprotein assays to longer-term proliferation and xenograft studies. Its strongest use is as a mechanistic bridge between pathway suppression, mutation-defined tumor biology, and testable radioresistance hypotheses.
-
HyperFluor™ 488 for FXR Condensate Imaging
2026-09-18
Learn how the HyperFluor™ 488 Rabbit Anti-Goat IgG (H+L) Antibody can support fluorescence-based studies of FXR condensates and coronavirus replication-organelle organization. This guide connects secondary-antibody design with controls, spatial readouts, and the mechanistic findings of a 2024 cell-biology study.
-
Oral Dextran Microgels for Local Colon Cancer Therapy
2026-09-17
The reference study develops an orally administered, sequentially targeted system that combines cisplatin and SPION-mediated magnetothermal therapy within lipid nanoparticles protected by dextran microgels. Its design concentrates treatment in the colon, promotes uptake by folate receptor-expressing tumor cells, and limits premature gastrointestinal transport, providing a useful framework for local colorectal cancer research.
-
Dopamine–cAMP/PKA/CREB Control of Osteoclasts
2026-09-17
Wang et al. identify a D2R/cAMP/PKA/CREB signaling axis through which dopamine suppresses osteoclast differentiation. The study connects neurotransmitter signaling with bone remodeling and uses pharmacological pathway-rescue experiments to support CREB as a key mediator of dopamine’s anti-osteoclastogenic effect.
-
Cy5 Goat Anti-Rabbit IgG (H+L) Antibody Workflow
2026-09-16
Build sensitive rabbit-primary assays for MAVS, ASB3, TBK1, and IRF3 using a Cy5 secondary that supports imaging, western blotting, tissue staining, and flow cytometry. This practical guide combines pathway-focused experimental design with starting conditions, storage guidance, and troubleshooting for cleaner fluorescence data.
-
Sulfur Supply Delays Soybean Nodule Senescence
2026-09-15
The reference study identifies sulfur delivery to the symbiosome as a regulatory bottleneck in soybean nodule longevity. Its genetic and elemental analyses connect SULTR-mediated sulfur transport with glutathione-dependent scavenging of reactive nitrogen species, suggesting a route to preserve symbiotic nitrogen fixation under senescence-inducing conditions.
-
Gepotidacin (GSK2140944) Assay Workflows
2026-09-15
Build a practical Gepotidacin workflow that connects biochemical topoisomerase inhibition with phenotypic susceptibility and resistance profiling. The approach combines controlled compound handling, orthogonal readouts, and lessons from pathway-engineering research without overstating what the current evidence supports.
-
Ertugliflozin, Brain Insulin Signaling, and Tau
2026-09-14
The reference study examined whether ertugliflozin could counter cognitive and hippocampal abnormalities in a streptozotocin-based model of brain insulin resistance. Its main contribution was linking improved behavioral performance with reduced tau hyperphosphorylation, restored Akt/GSK3β signaling, and protection from cholinergic, mitochondrial, apoptotic, and synaptic disturbances.
-
CD44 Metabolic Rewiring in IDH-Mutant Leukemia
2026-09-14
The reference study identifies CD44 as a metabolic dependency in IDH-mutant leukemia, linking adhesion signaling to NADPH production and sustained R-2HG synthesis. Its isogenic CRISPR-based design supports a mechanistic model in which CD44 blockade may complement mutant IDH inhibition and help address resistance in acute myeloid leukemia research.
-
CKI 7: A Translational Lens on CK1 Biology
2026-09-13
CKI 7 dihydrochloride is more than a pathway reagent: it is a strategic perturbation tool for testing how Casein kinase 1 activity shapes Wnt signaling, circadian control, apoptosis, and disease-relevant phenotypes. This article places CK1 inhibition alongside the MAPK10–KRT16–RNF213 metastasis axis while clearly separating established evidence from hypothesis-generating translational opportunities.